Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Appunti di Terapia

PDF MeBrain

Terapia breve per la polmonite non complicata acquisita in comunità in età pediatrica: si può fare!

Short therapy for uncomplicated community-acquired pneumonia in paediatric age: it is possible!

Angela Troisi, Alessandra Iacono, Federico Marchetti
UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna

Febbraio 2023 | DOI: 10.53126/MEBXXVIF031

Abstract
The paper reports the results published in the journal JAMA Pediatrics in November 2022 of a systematic review and meta-analysis comparing brief therapy and prolonged therapy for the treatment of non-severe community-acquired pneumonia (CAP) with the same oral antibiotic. The results suggest the non-inferiority of a short versus a long cycle in children aged 2 to 59 months. In addition, short-term antibiotic therapy improves adherence, reduces adverse effects and drug costs, and reduces caregiver work absenteeism. Paediatricians should prescribe 5 days of antibiotic therapy with amoxicillin (90 mg/kg/day in 3 doses) for non-severe CAP, taking into account the results of several randomized clinical trials that are now available.
Riassunto
Si riportano i risultati pubblicati sulla rivista JAMA Pediatrics nel mese di novembre 2022 di una revisione sistematica e di una metanalisi che mettono a confronto per la cura della polmonite acquisita in comunità (CAP) non grave la terapia breve e la terapia prolungata utilizzando lo stesso antibiotico orale. I risultati suggeriscono la non inferiorità di un ciclo breve rispetto a quello lungo nei bambini di età compresa tra 2 e 59 mesi. Inoltre, la terapia antibiotica di breve durata migliora l’aderenza, riduce gli effetti avversi e i costi del farmaco e l’assenteismo lavorativo del caregiver. I pediatri dovrebbero prescrivere 5 giorni di terapia antibiotica con amoxicillina (90 mg/kg/giorno in 3 dosi) per la CAP non grave, alla luce dei risultati dei diversi studi clinici randomizzati ora disponibili.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  1. Iacono A, Troisi A, Marchetti F. La polmonite acquisita in comunità. Medico e Bambino 2021;40(8):515-8. doi: 10.53126/MEB40515.
  2. Pernica JM, Harman S, Kam AJ et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia: The SAFER Randomized Clinical Trial. JAMA Pediatr 2021;175(5):475-82. doi: 10.1001/jamapediatrics.2020.6735.
  3. Li Q, Zhou Q, Florez ID, Mathew JL et al. Short-course vs long-course antibiotic therapy for children with nonsevere community-acquired pneumonia: a systematic review and meta-analysis. JAMA Pediatr 2022;176(12):1199-207. doi: 10.1001/jamapediatrics.2022.4123.
  4. Williams DJ, Creech CB, Walter EB, et al.; The DMID 14-0079 Study Team. The DMID 14-0079 Study Team. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr 2022;176(3):253-261. doi:10.1001/jamapediatrics. 2021.5547.
  5. Bielicki JA, StöhrW, Barratt S, et al; PERUKI, GAPRUKI, and the CAP-IT Trial Group. Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized clinical trial. JAMA 2021;326(17):1713-24. doi: 10.1001/jama.2021.17843.
  6. Ginsburg AS, Mvalo T, Nkwopara E, et al. Amoxicillin for 3 or 5 days for chest-indrawing pneumonia in Malawian children. N Engl J Med 2020;383(1):13-23. doi: 10.1056/NEJMoa1912400.
  7. Greenberg D, Givon-Lavi N, Sadaka Y, et al. Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial. Pediatr Infect Dis J 2014;33(2):136-42. doi: 10.1097/INF.0000000000000023.
  8. Agarwal G, Awasthi S, Kabra SK, et al.; ISCAP Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004;328(7443):791. doi: 10.1136/bmj.38049.490255.DE.
  9. WHO. Kartasasmita C, Saha S; Short Course Cotrimoxazole Study Group (eds). Consultative meeting to review evidence and research priorities in the management of acute respiratory infections (ARI). Accessed May 17, 2022.
  10. Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) Pneumonia Study Group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360(9336):835-41. doi: 10.1016/S0140-6736(02)09994-4.
  11. Lupisan SP, Medalla FM, Miguel CA, et al. A randomised, placebo-controlled trial of short course cotrimoxazole for the treatment of pneumonia in Filipino children. Philipp J Microbiol Infect Dis 1999;28:15-20.
  12. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008;(2):CD005976. doi: 10.1002/14651858.CD005976.pub2.
  13. Harris M, Clark J, Coote N, et al.; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011;66 Suppl2:ii1-23. doi: 10.1136/thoraxjnl-2011-200598.
  14. Bradley JS, Byington CL, Shah SS, et al.; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Paediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53(7): 617-30. doi: 10.1093/cid/cir625.
  15. Murphy S, Thomson L. NICE community-acquired pneumonia guideline review. Arch Dis Child Educ Pract Ed 2021;106(5):296-8. doi: 10.1136/archdischild-2020-319376.
  16. World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries. Accessed May 17, 2022.
  17. Florin TA, Ambroggio L, Brokamp C, et al. Biomarkers and disease severity in children with community-acquired pneumonia. Pediatrics 2020;145(6):e20193728. doi: 10.1542/peds.2019-3728.
  18. Farneti C, Vieni G, Marchetti F. La radiografia del torace nella broncopolmonite: inutile nella maggioranza dei casi? Medico e Bambino 2018;37(2):93-5.